Fonda Su

Title: Fonda Su: Innovator in Injectable Epinephrine Formulations

Introduction

Fonda Su is a notable inventor based in Hacienda Heights, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable epinephrine formulations. Her work focuses on enhancing the stability and retention of epinephrine over extended storage periods.

Latest Patents

Fonda Su holds a patent for her innovative formulation titled "Injectable epinephrine formulations demonstrating stability over time." This patent discloses pharmaceutical formulations that include epinephrine with increased retention over long-term storage, specifically up to 30 months. The formulation comprises 0.1 mg/mL of epinephrine or a pharmaceutically acceptable salt, along with a tonicity regulating agent of 8.2 mg/mL sodium chloride. It also includes a pH adjusting agent, which consists of a mixture of 1.5 mg/mL sodium citrate dihydrate and 3.3 mg/mL citric acid monohydrate, with sodium hydroxide added as needed to maintain the pH between 3.6 and 4.0. Additionally, the formulation contains 0.075 mg/mL of sodium metabisulfite and 4 μg/mL of ethylene diamine tetra-acetate disodium. Remarkably, the formulation achieves an API recovery of 94.5% or more after at least 30 months of storage at defined long-term conditions of 25° C.±2° C. at 1 atmosphere.

Career Highlights

Fonda Su is currently employed at Amphastar Pharmaceuticals, Inc., where she continues to advance her research in pharmaceutical formulations. Her innovative work has positioned her as a key figure in the development of stable injectable medications.

Collaborations

Fonda has collaborated with notable colleagues, including Jie Fei Ding and Justin Jun Wei, contributing to the advancement of pharmaceutical sciences through teamwork and shared expertise.

Conclusion

Fonda Su's contributions to the field of injectable epinephrine formulations demonstrate her commitment to improving pharmaceutical stability and efficacy. Her innovative patent reflects her dedication to enhancing patient care through advanced medication formulations.